Stay updated on Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial
Sign up to get notified when there's something new on the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page.

Latest updates to the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page
- CheckyesterdayChange DetectedThe banner about lapse in government funding was removed from the page. Core study details, locations, and planned outcomes remain unchanged.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedNo significant additions or deletions detected on the Study Details page for NCT03861273; the study information and location list remain unchanged.SummaryDifference0.3%

- Check44 days agoChange DetectedThe page has been updated to a new revision (v3.2.0) with updated bibliographic details, and a government operating-status notice has been added; an earlier online-ahead-of-print citation has been removed, indicating a shift in reference status.SummaryDifference2%

- Check51 days agoChange DetectedUpdate: standardize disease name to 'Hemophilia B' and bump revision to v3.1.0.SummaryDifference0.1%

- Check58 days agoChange DetectedUpdated trial eligibility from FIX:C = 2% to a broader range (up to 2%), added a future milestone date, and removed an earlier specific date and count.SummaryDifference0.3%

- Check65 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page.